Singulex Inc
Formerly BioProfile, L.L.C., BioProfile Corporation
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2013 | $12 M | No. 3 | $10 to $50 million | equity, options | SEC | |
| Feb 2012 | $15 M | No. 2 | $10 to $50 million | equity | SEC | |
| May 2011 | $10 M | No. 1 | $2 to $10 million | equity, debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Singulex Inc chose not to state its revenue in its newest notice of a funding round (Jun 2013).
SEC Form D · Jun 2013
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jun 2013
That is all the official record says: Singulex Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Singulex Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 8 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Guido L. Baechler | Executive officer | Jun 2013 |
| Michael K. Bell | Executive officer | Jun 2013 |
| Philippe J. Goix | Executive officer | Mar 2012 |
| Philippe Goix | Executive officer | Aug 2011 |
| Andre R. Marion | Director | Jun 2013 |
| Carl L. Gordon | Director | Jun 2013 |
| Fred K. Vogt | Director | Jun 2013 |
| Gregory R. Johnson | Director | Jun 2013 |
| Guido L. Baechler | Director | Jun 2013 |
| Heiner J. Dreismann | Director | Jun 2013 |
| Philippe J. Goix | Director | Jun 2013 |
| R. Douglas K. Norby | Director | Jun 2013 |
| Stephen L. Rose | Director | Jun 2013 |
| Hironori L. Hozoji | Director | Mar 2012 |
| Andre Marion | Director | Aug 2011 |
| Carl Gordon | Director | Aug 2011 |
| Fred Vogt | Director | Aug 2011 |
| Gregory Johnson | Director | Aug 2011 |
| Heiner Dreismann | Director | Aug 2011 |
| Hironori Hozoji | Director | Aug 2011 |
| Philippe Goix | Director | Aug 2011 |
| Stephen Rose | Director | Aug 2011 |